Aimovig for Migraine Prevention: What Patients Should Know

Aimovig (erenumab-aooe) is a prescription injection for preventing migraine in adults. It is taken monthly, rather than when an attack begins. For someone considering an injectable preventive, the central questions are whether it fits their medical history, whether the benefit justifies continuing, and whether they can obtain each dose reliably. [1]

What does Aimovig do?

Aimovig is a monoclonal antibody, a medicine designed to attach to a specific target. It blocks the receptor for calcitonin gene-related peptide, or CGRP, a signal involved in migraine. Other CGRP antibodies attach to the signal itself. That difference explains how the medicines work; it does not tell an individual which will work best. [1]

Prevention is worth discussing when attacks interfere with daily life or occur frequently. Current American Headache Society guidance includes CGRP treatments among first-line preventive options. Choosing a medicine should include evidence, side effects, patient priorities, and access. [4] Bring examples of what migraine interrupts: work, caring for family, exercise, sleep, or plans you repeatedly cancel.

Aimovig does not replace a plan for attacks that still occur. Read Medicines for attacks versus prevention to understand how the two parts of treatment fit together. A preventive can be worthwhile even when an acute medicine remains necessary.

How is Aimovig taken?

The U.S. label describes 70 mg injected under the skin once monthly; some patients may benefit from 140 mg monthly. It comes in a prefilled autoinjector or syringe. These are label details for education, not instructions to choose or change your own dose. Follow the prescription and the instructions supplied with your device. [1]

A clinician should teach you or your caregiver how to give the injection before home use. The manufacturer provides device instructions and a demonstration. [3] Ask to practice the sequence with a demonstration device if available. If hand strength, vision, or needle anxiety makes self-injection difficult, say so before filling the prescription. A short explanation on a screen may not address the particular step you find difficult.

Make a practical plan for pharmacy delivery, storage, travel, and used-device disposal. Ask the pharmacist what to do if a shipment arrives warm or a device is damaged. Keep the original instructions accessible. If you cannot tell whether an injection delivered the full dose, ask for advice rather than guessing and giving another injection.

How will you know whether it is helping?

A randomized trial in adults with episodic migraine found that erenumab reduced migraine days more than placebo. It also assessed acute-medication use and headache impact. Those findings support prevention, but a study average cannot predict your result. [5] Some people notice a worthwhile change; others need a different approach. The aim is a measurable improvement that matters to you.

Agree on a follow-up date and record a baseline before starting when feasible. Use a simple calendar rather than relying on memory. Useful entries include:

• Days with headache and days with migraine symptoms.
• Days you used an acute medicine, with its name.
• Activities missed or completed with difficulty.
• Injection dates, side effects, and any interrupted doses.

A month with fewer attacks but several completely lost workdays may feel different from a month with the same number of milder attacks. Report both. Also explain an unusually stressful month, a refill delay, or another treatment change. These details help the clinician interpret the record without attributing every change to Aimovig.

Which side effects need attention?

Injection-site discomfort, redness or swelling, and constipation are common labeled side effects. [2] The important safety plan also covers less common, potentially serious problems:

• Allergic reactions: Facial, mouth, tongue, or throat swelling or difficulty breathing requires emergency help. [2] Reactions can be delayed, including more than a week after a dose. A previous serious allergy to Aimovig or its ingredients rules out its use. [1]
• Severe constipation: Serious complications have included hospital care or surgery. Contact a clinician promptly for severe constipation, especially with persistent or severe belly pain, vomiting, abdominal swelling, or bloating. [2]
• High blood pressure: New hypertension or worsening existing hypertension can occur. Report increased readings and agree on a monitoring plan. [2]
• Raynaud's phenomenon: New or worsening circulation symptoms can include cold, painful, numb, or discolored fingers or toes. [6] Stop Aimovig and contact the prescribing clinician if these develop, as the label advises. [1]

Do not wait for a routine follow-up to report a concerning reaction. Write down when it started and its relationship to the injection. Bring your medicine list when seeking care.

A checklist for the prescribing conversation

Discuss pregnancy plans and breastfeeding before treatment. The patient information says the effects on an unborn baby and whether Aimovig enters breast milk are unknown. A pregnancy exposure registry is available. [6] If pregnancy occurs during treatment, contact your clinician for an individualized plan.

Frequently asked questions

Does Aimovig stop a migraine already underway?

Its role is prevention. Keep the acute-treatment instructions your clinician provides and ask how to handle attacks that break through. Taking extra preventive injections is not a substitute for that plan.

Is Aimovig the best CGRP medicine?

There is no universal best choice. Your response, medical history, preferred schedule, injection experience, and pharmacy access all matter. Another person's success or online review is useful context, not a prediction.

What if the pharmacy says insurance will not cover it?

Ask what is missing: prior authorization, a preferred alternative, documentation, or a quantity limit. Read Why prescriptions sometimes need prior authorization. Record the reason for any delay so the clinician can distinguish an interrupted trial from a medication that did not help.

Discuss prevention with TeleHeadache

Eligible adults 18 and older who are physically located in Florida can seek a TeleHeadache eligibility assessment for appropriate nonurgent headache care. A clinician can consider preventive options and prescribe when appropriate. Medication availability, insurance approval, and pharmacy costs are separate from the clinical membership. Bring your headache record and medicine list to make that assessment useful.

Official medication information and further reading

Official Aimovig website · Aimovig on Drugs.com · Drugs.com

Use the current U.S. prescribing information and your own prescription instructions when discussing this medicine with your clinician or pharmacist.

Educational information supports a discussion with your clinician and does not replace individualized medical evaluation. Medication choice and prescribing require clinical review.